Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
Clinical trial NCT05125055 · RECRUITING
Trial details
- NCT number
- NCT05125055
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2024-09-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.